PF-Atlas › Clinical Trials › NCT00432861

Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis

PANCRECARB® · Phase 3

Registry ID

NCT00432861

Phase

Phase 3

Status

Completed

Drug / intervention

PANCRECARB® (pancrelipase)

Sponsor

Digestive Care, Inc.

Start

2007-01

About this trial

PANCRECARB® is evaluated in NCT00432861, a Phase 3 idiopathic pulmonary fibrosis study sponsored by Digestive Care, Inc.. Current status: Completed.

View NCT00432861 on ClinicalTrials.gov →

Explore related

All PANCRECARB® trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00432861 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.